<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0009450" disease_type="Disease or Syndrome" abbrv="">Infectious diseases</z:e> are important causes of morbidity and mortality in immunocompromised patients with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e>, severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA), and <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Major advances in <z:e sem="disease" ids="C0009450" disease_type="Disease or Syndrome" abbrv="">infectious diseases</z:e> supportive care have been critical to improving the outcome of patients suffering from these life-threatening diseases </plain></SENT>
<SENT sid="2" pm="."><plain>Advances in diagnosis, treatment, and prevention of life-threatening <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> have reduced morbidity and mortality, improved quality of life, and enabled the use of potentially curative chemotherapy, radiation, hematopoietic stem cell transplantation (HSCT), and immunosuppressive therapy to patients battling these devastating diseases </plain></SENT>
<SENT sid="3" pm="."><plain>Despite these advances, the continued development of antimicrobial resistance, emergence of new pathogens, and the evolution of host factors present evolving challenges to the successful management of infectious complications in this expanding patient population </plain></SENT>
</text></document>